Blood test may guide stroke prevention in thousands
NCT ID NCT06853535
First seen Jan 25, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tests whether using a platelet function blood test to choose anti-clotting medication can reduce the risk of another stroke in people who recently had a mild stroke or high-risk TIA. About 5,138 participants will either receive standard care or have their medication switched to ticagrelor if the test shows they don't respond well to clopidogrel. The main goal is to see if this personalized approach lowers the chance of a recurrent stroke within 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.